Sagimet Biosciences Inc. (SGMT)

Sagimet Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	32.5	75.84	75.14	0.16	56.73	68.7
Short-Term Investments	84.2	75.41	19.76	32.19	-	-
Cash & Short-Term Investments	116.69	151.25	94.9	32.35	56.73	68.7
Cash Growth	-23.47%	59.38%	193.39%	-42.98%	-17.42%	572.76%
Prepaid Expenses	2.29	1.06	1.35	0.41	0.42	-
Other Current Assets	0.5	0.46	0.4	0.03	1.51	0.04
Total Current Assets	119.48	152.77	96.65	32.79	58.66	68.74
Property, Plant & Equipment	0.12	0.08	0.07	0.21	0.34	0.19
Long-Term Investments	8.81	7.41	-	-	-	-
Other Long-Term Assets	-	-	-	0.03	0.03	0.03
Total Assets	128.4	160.26	96.72	33.03	59.03	68.96
Accounts Payable	4.24	1.43	0.19	1.13	0.76	0.51
Accrued Expenses	4.78	2.95	4.85	3.96	1.32	1.01
Current Portion of Leases	0.12	0.08	0.07	0.13	0.12	0.15
Other Current Liabilities	0.01	0.01	0.56	0.06	0.24	0.24
Total Current Liabilities	9.15	4.45	5.65	5.28	2.44	1.91
Long-Term Leases	-	-	-	0.08	0.22	0.07
Other Long-Term Liabilities	-	-	-	0	-	-
Total Liabilities	9.15	4.45	5.65	5.36	2.66	1.98
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	455.92	450.88	340.78	35	33.11	31.02
Retained Earnings	-336.78	-295.31	-249.74	-221.87	-191.37	-166.93
Comprehensive Income & Other	0.12	0.23	0.03	-0.08	-	-
Total Common Equity	119.26	155.81	91.07	-186.95	-158.26	-135.91
Shareholders' Equity	119.26	155.81	91.07	27.67	56.37	66.98
Total Liabilities & Equity	128.4	160.26	96.72	33.03	59.03	68.96
Total Debt	0.12	0.08	0.07	0.21	0.35	0.21
Net Cash (Debt)	125.38	158.58	94.83	32.13	56.38	68.49
Net Cash Growth	-26.18%	67.22%	195.11%	-43.01%	-17.68%	593.87%
Net Cash Per Share	3.88	5.06	9.07	174.06	459.97	709.34
Filing Date Shares Outstanding	32.52	32.2	31.91	22.9	0.12	0.1
Total Common Shares Outstanding	32.52	32.2	22.9	0.19	0.12	0.1
Working Capital	110.33	148.32	90.99	27.51	56.22	66.83
Book Value Per Share	3.67	4.84	3.98	-1010.08	-1291.08	-1407.55
Tangible Book Value	119.26	155.81	91.07	-186.95	-158.26	-135.91
Tangible Book Value Per Share	3.67	4.84	3.98	-1010.08	-1291.08	-1407.55

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q